372
Participants
Start Date
September 30, 2013
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
Osiro Hybrid Drug-Eluting Stent
Osiro Hybrid Drug-Eluting Stent (Biotronik AG, Bulach, Switzeland)
Resolute Integrity
Resolute Integrity zotarolimus-eluting stent (Medtronic Cardiovascular, CA, Minnesota, USA)
Korea University Ansan Hospital, Ansan
Chungbuk University Hospital, Cheongju-si
Inje University Ilsan Paik Hospital, Ilsan
Inha University Hospital, Incheon
Jeju University Hospital, Jeju City
Seoul National University Bundang Hospital, Seongnam
Boramae Medical Center, Seoul
Kyung Hee University Hospital at Gangdong Hospital, Seoul
Jeju National University Hospital
OTHER
Chungbuk National University Hospital
OTHER
SMG-SNU Boramae Medical Center
OTHER
Korea University
OTHER
Inje University
OTHER
Kyung Hee University Hospital at Gangdong
OTHER
Inha University Hospital
OTHER
Seoul National University Bundang Hospital
OTHER